Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

P&P PHARMACONSULTING : revenue, balance sheet and financial ratios

P&P PHARMACONSULTING is a French company founded 10 years ago, specialized in the sector Ingénierie, études techniques. Based in CERNAY-LA-VILLE (78720), this company of category PME shows in 2015 a net income negative of -17 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-11

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - P&P PHARMACONSULTING (SIREN 812511624)
Indicator 2015
Revenue N/C
Net income -17 194 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2015, P&P PHARMACONSULTING records a net loss of 17 k€. This deficit will reduce equity on the balance sheet.

Net income (2015) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-17 194 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at -62%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -201%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2015) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

-61.751%

Financial autonomy (2015) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

-200.719%

Asset age ratio (2015) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

96.5%

Solvency indicators evolution
P&P PHARMACONSULTING

Sector positioning

Debt ratio
-61.75 2015
2015
Q1: 0.0
Med: 2.8
Q3: 39.7
Excellent

In 2015, the debt ratio of P&P PHARMACONSULTING (-61.75) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
-200.72% 2015
2015
Q1: 1.57%
Med: 27.27%
Q3: 56.81%
Watch

In 2015, the financial autonomy of P&P PHARMACONSULTING (-200.7%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 48.23. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2015) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

48.226

Liquidity indicators evolution
P&P PHARMACONSULTING

Sector positioning

Liquidity ratio
48.23 2015
2015
Q1: 110.3
Med: 172.67
Q3: 329.95
Watch

In 2015, the liquidity ratio of P&P PHARMACONSULTING (48.23) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Positioning of P&P PHARMACONSULTING in its sector

Comparison with sector Ingénierie, études techniques

Similar companies (Ingénierie, études techniques)

Compare P&P PHARMACONSULTING with other companies in the same sector:

Voir toutes les statistiques du secteur Ingénierie, études techniques

Frequently asked questions about P&P PHARMACONSULTING

What is the revenue of P&P PHARMACONSULTING ?

The revenue of P&P PHARMACONSULTING is not publicly disclosed (confidential accounts filed with INPI).

Is P&P PHARMACONSULTING profitable?

P&P PHARMACONSULTING recorded a net loss in 2015.

Where is the headquarters of P&P PHARMACONSULTING ?

The headquarters of P&P PHARMACONSULTING is located in CERNAY-LA-VILLE (78720), in the department Yvelines.

Where to find the tax return of P&P PHARMACONSULTING ?

The tax return of P&P PHARMACONSULTING is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does P&P PHARMACONSULTING operate?

P&P PHARMACONSULTING operates in the sector Ingénierie, études techniques (NAF code 71.12B). See the 'Sector positioning' section above to compare the company with its competitors.